The platform analyzes infrared spectroscopy data from a small sample of blood with proprietary algorithms to detect cancer early.

The award supports development of a portable test system using the firm's protein nucleic acid probes and semiconductor sensor tech.

The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Life Line aims to offer Lucent's blood-based testing through its mobile delivery model at urban and rural community health screening events.

Natera expects additional reimbursement coverage for its oncology tests in 2026 that may drive increases in average selling prices and volumes, company executives said on Thursday. Separately this ...

BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...

Moffit Cancer Center researchers found four "protein EpiScores" that were associated with disease-free survival, one of which was also associated with overall survival.

The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.

NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...

The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.